Literature DB >> 8070503

Low catechol-O-methyltransferase activity in a Saami population.

B Klemetsdal1, B Straume, T Giverhaug, J Aarbakke.   

Abstract

Catechol-O-methyltransferase (COMT) catalyzes the O-methylation of catechol hormones, neurotransmitters and certain drugs. It is subject to genetic polymorphism and ethnic differences. High red blood cell (RBC) COMT activity has been correlated with a poor response to levodopa treatment in Parkinson's disease. RBC COMT was determined in a Norwegian population (n = 213) of whom 115 were Saami (Laaps). The Saami had 16.5% lower RBC COMT activity compared to a non-Saami population sample from the northern part of Norway (n = 50), 13.9 vs. 16.4 units/ml RBC (U) (P = 0.04). This is the first report of any population with lower RBC COMT activity than a Caucasian population. A wide range of RBC COMT activities was found in the entire population examined (1.3-38.3 U).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8070503     DOI: 10.1007/bf00192554

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  29 in total

Review 1.  Catechol-O-methyl transferase: pharmacological aspects and physiological role.

Authors:  H C Guldberg; C A Marsden
Journal:  Pharmacol Rev       Date:  1975-06       Impact factor: 25.468

2.  Enzymatic O-methylation of epinephrine and other catechols.

Authors:  J AXELROD; R TOMCHICK
Journal:  J Biol Chem       Date:  1958-09       Impact factor: 5.157

3.  Diversity of some gene frequencies in European and Asian populations. V. Steep multilocus clines.

Authors:  G Barbujani; G M Jacquez; L Ligi
Journal:  Am J Hum Genet       Date:  1990-11       Impact factor: 11.025

4.  Does O-methyl-dopa play a role in levodopa-induced dyskinesias?

Authors:  C Feuerstein; M Tanche; F Serre; M Gavend; J Pellat; J Perret
Journal:  Acta Neurol Scand       Date:  1977-07       Impact factor: 3.209

5.  Genetics of red cell COMT activity: analysis of thermal stability and family data.

Authors:  R S Spielman; R M Weinshilboum
Journal:  Am J Med Genet       Date:  1981

6.  Microassay of human erythrocyte catechol-O-methyltransferase: removal of inhibitory calcium ion with chelating resin.

Authors:  F A Raymond; R M Weinshilboum
Journal:  Clin Chim Acta       Date:  1975-01-20       Impact factor: 3.786

7.  Difference in erythrocyte catechol-O-methyltransferase activity between Orientals and Caucasians: difference in levodopa tolerance.

Authors:  L Rivera-Calimlim; D K Reilly
Journal:  Clin Pharmacol Ther       Date:  1984-06       Impact factor: 6.875

8.  Erythrocyte catechol-O-methyltransferase activity in a Swedish population.

Authors:  Y Floderus; S B Ross; L Wetterberg
Journal:  Clin Genet       Date:  1981-05       Impact factor: 4.438

9.  Human liver thiopurine methyltransferase pharmacogenetics: biochemical properties, liver-erythrocyte correlation and presence of isozymes.

Authors:  C L Szumlanski; R Honchel; M C Scott; R M Weinshilboum
Journal:  Pharmacogenetics       Date:  1992-08

10.  3-O-methyldopa and the response to levodopa in Parkinson's disease.

Authors:  J G Nutt; W R Woodward; S T Gancher; D Merrick
Journal:  Ann Neurol       Date:  1987-06       Impact factor: 10.422

View more
  3 in total

1.  Tryptophan hydroxylase and catechol-O-methyltransferase gene polymorphisms: relationships to monoamine metabolite concentrations in CSF of healthy volunteers.

Authors:  E G Jönsson; D Goldman; G Spurlock; J P Gustavsson; D A Nielsen; M Linnoila; M J Owen; G C Sedvall
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

Review 2.  The effect of green tea extract on fat oxidation at rest and during exercise: evidence of efficacy and proposed mechanisms.

Authors:  Adrian B Hodgson; Rebecca K Randell; Asker E Jeukendrup
Journal:  Adv Nutr       Date:  2013-03-01       Impact factor: 8.701

3.  An Investigation of the COMT Gene Val158Met Polymorphism in Patients Admitted to the Emergency Department Because of Synthetic Cannabinoid Use.

Authors:  Y Nennicioglu; H Kaya; S Eraybar; S Atmaca; O Gorukmez; E Armagan
Journal:  Balkan J Med Genet       Date:  2020-08-26       Impact factor: 0.519

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.